Clinical Diagnostics Technology & Disease Research News | 360Dx
网页The change applies to qualitative and quantitative hepatitis B virus antigen, antibody, and nucleic acid assays that are used to detect acute and chronic infections. Emerging economic and technological trends in the clinical diagnostic market. Diagnostics market and reports on regulatory, reimbursement, and policy issues that impact the ...
About Us - 360Dx
网页About Us. 360Dx is published by GenomeWeb, an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and diagnostics. GenomeWeb is a family brand of Crain ...
European Project to Develop Graphene-Based Point-of-Care …
网页5 小时之前 · NEW YORK – If all goes as planned, a consortium of European researchers and technology and services providers could be ready to launch at least one test for the early-stage detection of Alzheimer’s disease within three years, a goal it has been striving for nearly a year. The consortium dubbed 2D-BioPAD is a Horizon Europe project with a budget of €6 million ($6.7 million) that commenced ...
Diagnostic Technologies and Applications - 360Dx
网页Sep 19, 2024. New Multi-Cancer Detection Data Speak to Both Promises and Cautions of Blood-Based Assays. Sep 18, 2024. Hedera Dx Expects Increased Liquid Biopsy Adoption With Real-World Data Cancer Registries. News and analysis on diagnostic technologies and applications from 360Dx.
Top Five Articles on 360Dx Last Week: Digital Pathology Adoption; …
网页6 小时之前 · NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: 1) As Digital Pathology Slowly Expands, Industry Anxiously Awaits a Breakout Moment 2) FDA to Reclassify Hepatitis B Virus Tests as Moderate Risk Devices 3) Bio-Rad Laboratories, Sysmex America Partner for QC Software 4) Fujirebio Files Blood-Based Alzheimer's Test With FDA
Digital Pathology Firm Mindpeak Raises $15.3M in Series A …
网页13 小时之前 · NEW YORK – German digital pathology company Mindpeak announced Monday that it has raised $15.3 million in a Series A financing round. The round was led by Zeiss Ventures and InnoVentureFund with participation from AI.FUND and the European Innovation Council Fund, among others. The new funding will …
360Dx Top 30 Slides 1 Percent in January
网页2024年2月1日 · 360Dx Top 30 Slides 1 Percent in January. Note: The 360Dx Top 30 has been updated with new entries Biodesix, MDxHealth, OraSure Technologies, and Sera Prognostics based on market cap as of beginning of trading in January 2024. LumiraDx was removed due to the acquisition of most of its assets by Roche, and Accelerate Diagnostics, Burning Rock ...
coronavirus Diagnostics News | 360Dx
网页coronavirus. Breaking news on coronavirus testing, with real-time reporting on assays to detect the SARS-CoV2 coronavirus, which causes COVID-19. Check out our Coronavirus Test Tracker for the latest information on the regulatory status of these tests in the US, European, and Asian markets.
Coronavirus Test Tracker: Commercially Available COVID-19 ... - 360Dx
网页As labs and diagnostic developers race to meet demand for assays to detect the SARS-CoV-2 coronavirus, 360Dx is updating this tracker on a regular basis in order to provide readers with up-to-date and accurate information on the regulatory status of these tests in the US, European, and Asian markets. The tracker includes only those tests that ...
Protean BioDiagnostics to Market Nanostics Prostate Cancer Risk …
网页6 天之前 · NEW YORK — Protean BioDiagnostics has signed an agreement to market Nanostics' prostate cancer risk assessment tool in the US, the companies said Tuesday. Called ClarityDx Prostate, the tool analyzes two blood-based biomarkers — total prostate-specific antigen (PSA) and free PSA — and up to five …